Clinical trial
TIPS Plus Half-dose Donafenib in AHCC with PVTT-associated Portal Hypertension
NCT06646198
Study timeline
Study start (actual)2024-10-08Date precision: day
Registry last updated2024-10-17
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Hepatocellular Carcinoma with PVTTunresolved
Interventions
Sponsors & collaborators
Fei Gaolead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06646198 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.